198 related articles for article (PubMed ID: 26916621)
1. Serum testosterone, testosterone replacement therapy and all-cause mortality in men with type 2 diabetes: retrospective consideration of the impact of PDE5 inhibitors and statins.
Hackett G; Heald AH; Sinclair A; Jones PW; Strange RC; Ramachandran S
Int J Clin Pract; 2016 Mar; 70(3):244-53. PubMed ID: 26916621
[TBL] [Abstract][Full Text] [Related]
2. Statin, testosterone and phosphodiesterase 5-inhibitor treatments and age related mortality in diabetes.
Hackett G; Jones PW; Strange RC; Ramachandran S
World J Diabetes; 2017 Mar; 8(3):104-111. PubMed ID: 28344753
[TBL] [Abstract][Full Text] [Related]
3. Long-term testosterone therapy in type 2 diabetes is associated with reduced mortality without improvement in conventional cardiovascular risk factors.
Hackett G; Cole N; Mulay A; Strange RC; Ramachandran S
BJU Int; 2019 Mar; 123(3):519-529. PubMed ID: 30216622
[TBL] [Abstract][Full Text] [Related]
4. Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes.
Muraleedharan V; Marsh H; Kapoor D; Channer KS; Jones TH
Eur J Endocrinol; 2013 Dec; 169(6):725-33. PubMed ID: 23999642
[TBL] [Abstract][Full Text] [Related]
5. The association of sex hormone-binding globulin with mortality is mediated by age and testosterone in men with type 2 diabetes.
Ramachandran S; Strange RC; Fryer AA; Saad F; Hackett GI
Andrology; 2018 Nov; 6(6):846-853. PubMed ID: 30006962
[TBL] [Abstract][Full Text] [Related]
6. PDE-5 inhibitors in monotherapy versus combination therapy in a sample of 1200 patients with erectile dysfunction.
Labairu-Huerta L; Padilla-Fernández B; Arrondo-Arrondo JL; Valverde-Martínez LS; Martín-Rodríguez A; Silva-Abuín JM; García-Cenador MB; Mirón-Canelo JA; Lorenzo-Gómez MF
Arch Ital Urol Androl; 2015 Sep; 87(3):204-9. PubMed ID: 26428641
[TBL] [Abstract][Full Text] [Related]
7. Association of sex hormone-binding globulin and free testosterone with mortality in men with type 2 diabetes mellitus.
Tint AN; Hoermann R; Wong H; Ekinci EI; MacIsaac RJ; Jerums G; Zajac JD; Grossmann M
Eur J Endocrinol; 2016 Jan; 174(1):59-68. PubMed ID: 26483395
[TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality.
Anderson SG; Hutchings DC; Woodward M; Rahimi K; Rutter MK; Kirby M; Hackett G; Trafford AW; Heald AH
Heart; 2016 Nov; 102(21):1750-1756. PubMed ID: 27465053
[TBL] [Abstract][Full Text] [Related]
9. Testosterone treatment and mortality in men with low testosterone levels.
Shores MM; Smith NL; Forsberg CW; Anawalt BD; Matsumoto AM
J Clin Endocrinol Metab; 2012 Jun; 97(6):2050-8. PubMed ID: 22496507
[TBL] [Abstract][Full Text] [Related]
10. Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction: a parallel, randomized trial.
Spitzer M; Basaria S; Travison TG; Davda MN; Paley A; Cohen B; Mazer NA; Knapp PE; Hanka S; Lakshman KM; Ulloor J; Zhang A; Orwoll K; Eder R; Collins L; Mohammed N; Rosen RC; DeRogatis L; Bhasin S
Ann Intern Med; 2012 Nov; 157(10):681-91. PubMed ID: 23165659
[TBL] [Abstract][Full Text] [Related]
11. Improved sexual function with testosterone replacement therapy in hypogonadal men: real-world data from the Testim Registry in the United States (TRiUS).
Khera M; Bhattacharya RK; Blick G; Kushner H; Nguyen D; Miner MM
J Sex Med; 2011 Nov; 8(11):3204-13. PubMed ID: 21834870
[TBL] [Abstract][Full Text] [Related]
12. Symptom report and treatment experience of hypogonadal men with and without type 2 diabetes in a United States health plan.
Shortridge EF; Polzer P; Donga P; Wade RL
Int J Clin Pract; 2015 Jul; 69(7):783-90. PubMed ID: 25854747
[TBL] [Abstract][Full Text] [Related]
13. Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men.
Sharma R; Oni OA; Gupta K; Chen G; Sharma M; Dawn B; Sharma R; Parashara D; Savin VJ; Ambrose JA; Barua RS
Eur Heart J; 2015 Oct; 36(40):2706-15. PubMed ID: 26248567
[TBL] [Abstract][Full Text] [Related]
14. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
Blick G
Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
[TBL] [Abstract][Full Text] [Related]
15. The response to testosterone undecanoate in men with type 2 diabetes is dependent on achieving threshold serum levels (the BLAST study).
Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P; Saghir A;
Int J Clin Pract; 2014 Feb; 68(2):203-15. PubMed ID: 24355040
[TBL] [Abstract][Full Text] [Related]
16. Effects of long-term testosterone replacement therapy, with a temporary intermission, on glycemic control of nine hypogonadal men with type 1 diabetes mellitus - a series of case reports.
Saad F; Yassin A; Almehmadi Y; Doros G; Gooren L
Aging Male; 2015; 18(3):164-8. PubMed ID: 26075537
[TBL] [Abstract][Full Text] [Related]
17. Does testosterone supplementation increase PDE5-inhibitor responses in difficult-to-treat erectile dysfunction patients?
Aversa A; Francomano D; Lenzi A
Expert Opin Pharmacother; 2015 Apr; 16(5):625-8. PubMed ID: 25643866
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of Men Undergoing Testosterone Replacement Therapy and Adherence to Follow-up Recommendations in Metropolitan Multicenter Health Care System.
Malik RD; Wang CE; Lapin B; Lakeman JC; Helfand BT
Urology; 2015 Jun; 85(6):1382-8. PubMed ID: 25862121
[TBL] [Abstract][Full Text] [Related]
19. 12-month observation of testosterone replacement effectiveness in a general population of men.
Miner MM; Bhattacharya RK; Blick G; Kushner H; Khera M
Postgrad Med; 2013 Mar; 125(2):8-18. PubMed ID: 23816767
[TBL] [Abstract][Full Text] [Related]
20. Relation of Testosterone Normalization to Mortality and Myocardial Infarction in Men With Previous Myocardial Infarction.
Oni OA; Dehkordi SHH; Jazayeri MA; Sharma R; Sharma M; Masoomi R; Sharma R; Gupta K; Barua RS
Am J Cardiol; 2019 Oct; 124(8):1171-1178. PubMed ID: 31409450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]